the raf v600e mutation in metastatic melanoma drives tumor growth in about half of all patients diagnosed with melanoma. patients given a drug that inhibits raf v600e effectively suppresses tumor growth, until the tumor develops drug resistance. what is the most likely reason for drug resistance in these tumors?
